This inventor holds 2 USPTO granted patents. Top assignees: Case Western Reserve University, Duke University, The University of Texas System. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:




Years Active: 2021-2025
Title: Dennis C Ko: Innovator in Autoimmune Disease Research
Introduction
Dennis C Ko is a prominent inventor based in Durham, NC (US). He has made significant contributions to the field of autoimmune disease research, holding 2 patents that focus on innovative methods for identifying individuals at higher risk of developing autoimmune conditions.
Latest Patents
One of his latest patents is titled "Method to identify subjects at higher risk to develop an autoimmune disease based on genetic and/or phenotypic screening for epistatic variants in DDX39B (RS2523506) and IL7R (RS6897932)." This invention includes a method, kits, and assays for identifying a human subject as having an increased risk of developing an autoimmune disease, particularly multiple sclerosis. The method involves obtaining a biological sample and detecting or measuring the levels of soluble Interleukin-7 receptor (sIL7R) and RNA Helicase DDX39B. A lower expression of DDX39B combined with a higher secretion of sIL7R indicates an increased risk of autoimmune disease. The invention also proposes methods for modifying treatment based on these findings.
Career Highlights
Throughout his career, Dennis C Ko has worked with esteemed institutions such as Case Western Reserve University and Duke University. His work has been instrumental in advancing the understanding of autoimmune diseases and their genetic underpinnings.
Collaborations
Some of his notable coworkers include Mariano A Garcia-Blanco and Lisa F Barcellos. Their collaborative efforts have contributed to the development of innovative research in the field.
Conclusion
Dennis C Ko's work in autoimmune disease research exemplifies the impact of innovative thinking in medicine. His patents and collaborations highlight the importance of genetic screening in identifying at-risk individuals, paving the way for improved treatment strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile